GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Chaoju Eye Care Holdings Ltd (HKSE:02219) » Definitions » ROC %

Chaoju Eye Care Holdings (HKSE:02219) ROC % : 19.84% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Chaoju Eye Care Holdings ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Chaoju Eye Care Holdings's annualized return on capital (ROC %) for the quarter that ended in Jun. 2024 was 19.84%.

As of today (2024-12-11), Chaoju Eye Care Holdings's WACC % is 10.41%. Chaoju Eye Care Holdings's ROC % is 18.49% (calculated using TTM income statement data). Chaoju Eye Care Holdings generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Chaoju Eye Care Holdings ROC % Historical Data

The historical data trend for Chaoju Eye Care Holdings's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chaoju Eye Care Holdings ROC % Chart

Chaoju Eye Care Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROC %
Get a 7-Day Free Trial 13.53 23.23 28.17 19.90 20.12

Chaoju Eye Care Holdings Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 28.14 15.92 25.34 16.03 19.84

Chaoju Eye Care Holdings ROC % Calculation

Chaoju Eye Care Holdings's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2023 is calculated as:

ROC % (A: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2022 ) + Invested Capital (A: Dec. 2023 ))/ count )
=331.716 * ( 1 - 26.24% )/( (1073.603 + 1358.6)/ 2 )
=244.6737216/1216.1015
=20.12 %

where

Invested Capital(A: Dec. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3040.982 - 213.976 - ( 1877.349 - max(0, 273.576 - 2026.979+1877.349))
=1073.603

Invested Capital(A: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3196.903 - 321.313 - ( 1698.224 - max(0, 374.881 - 1891.871+1698.224))
=1358.6

Chaoju Eye Care Holdings's annualized Return on Capital (ROC %) for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=358.62 * ( 1 - 25.62% )/( (1358.6 + 1329.746)/ 2 )
=266.741556/1344.173
=19.84 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3196.903 - 321.313 - ( 1698.224 - max(0, 374.881 - 1891.871+1698.224))
=1358.6

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3052.704 - 290.601 - ( 1568.618 - max(0, 347.843 - 1780.2+1568.618))
=1329.746

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chaoju Eye Care Holdings  (HKSE:02219) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Chaoju Eye Care Holdings's WACC % is 10.41%. Chaoju Eye Care Holdings's ROC % is 18.49% (calculated using TTM income statement data). Chaoju Eye Care Holdings generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Chaoju Eye Care Holdings ROC % Related Terms

Thank you for viewing the detailed overview of Chaoju Eye Care Holdings's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Chaoju Eye Care Holdings Business Description

Traded in Other Exchanges
N/A
Address
No. 14 Yard, West 3rd Ring South Road, Block A, Shouke Building, 24th Floor, East Zone, Fengtai District, Beijing, CHN
Chaoju Eye Care Holdings Ltd is a ophthalmic medical service group in North China engaged in engaged in the provision of in-patient services, out-patient services and sales of optical products. The company generate revenue from consumer ophthalmic services and basic ophthalmic services. The consumer ophthalmic services include treatments and prevention of various types of ophthalmic disorders, including refractive correction, myopia control and provision of optical products and services. The basic ophthalmic services include treatments of a wide range of common eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases and pediatric eye diseases.
Executives
Zhang Junfeng 2103 Interests held jointly with another person
Zhang Xiaoli 2103 Interests held jointly with another person
Zhang Bozhou 2103 Interests held jointly with another person
Areo Holdings Limited 2201 Interest of corporation controlled by you
Li Gabriel 2201 Interest of corporation controlled by you
Lam Lai Ming 2201 Interest of corporation controlled by you
Orchid Asia Vii, L.p. 2201 Interest of corporation controlled by you
Orchid Asia Vii Gp, Limited 2201 Interest of corporation controlled by you
Orchid Asia V Group, Limited 2201 Interest of corporation controlled by you
Orchid Asia V Group Management, Limited 2201 Interest of corporation controlled by you
Oavii Holdings, L.p. 2201 Interest of corporation controlled by you
Orchid Asia Vii Global Investment Limited 2101 Beneficial owner
Wang Stephen Hui 2201 Interest of corporation controlled by you
Xia Men Chao Xi Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Zhang Wenwen 2201 Interest of corporation controlled by you

Chaoju Eye Care Holdings Headlines

No Headlines